Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart syndrome

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart syndrome

Bibliographic Details
Main Authors:	Justin G. Reeves, MD, John S. Kim, MD, Max B. Mitchell, MD, Anthony C. McCanta, MD, FHRS
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	HeartRhythm Case Reports
Subjects:	Subcutaneous implantable cardioverter-defibrillator Congenital heart disease Hypoplastic left heart syndrome Ventricular fibrillation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027115000226

Similar Items

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease
by: Scott R. Ceresnak, MD, et al.
Published: (2015-07-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Practical Review and Real-World Use and Application
by: Mark E. Panna Jr, MD, FACC, FHRS, et al.
Published: (2016-02-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

Systemic infection due to subcutaneous implantable cardioverter-defibrillator implantation: Importance of early recognition and treatment of device pocket-related complications
by: Patrick M. Looser, MD, et al.
Published: (2017-01-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2017-02-01)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
by: Amit Noheria, MBBS, SM, et al.
Published: (2014-11-01)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
by: Nobuhiro Nishii, MD, et al.
Published: (2017-08-01)

Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD “Monaldi Care” registry
by: Berardo Sarubbi, et al.
Published: (2021-05-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

A cracking complication: Displacement of existing clavicle fracture complicating subcutaneous implantable cardioverter defibrillator implantation
by: Umar Ismail, et al.
Published: (2020-05-01)

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillatorKey Findings
by: Yuji Ishida, MD, PhD, et al.
Published: (2020-04-01)

Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
by: Mitsuhiro Fukata, MD, PhD, et al.
Published: (2017-09-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
by: Daisuke Ishigaki, M.D., et al.
Published: (2016-12-01)

Adjunctive hypnotic communication for analgosedation in subcutaneous implantable cardioverter defibrillator implantation. A prospective single center pilot study
by: Marco Scaglione, et al.
Published: (2021-08-01)

Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
by: Maciej Kempa, et al.
Published: (2021-07-01)

Hybrid subcutaneous and transvenous approach for cardiac resynchronization defibrillator implant in a patient with congenital heart disease and tricuspid bioprosthetic
by: Pooneh Nabavizadeh, MD, et al.
Published: (2020-01-01)

Implanted pacemaker and cardioverter-defibrillator in a patient with ectopia cordis
by: Tam Dan N. Pham, MD, et al.
Published: (2020-02-01)

The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
by: Ozcan Orscelik, et al.
Published: (2019-06-01)

T wave oversensing in subcutaneous implantable cardioverter defibrillator secondary to hematoma formation: A potential cause of early postimplantation inappropriate shocks
by: Ahmad Halawa, et al.
Published: (2019-02-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Subcutaneous ICD implant complicated by an intraperitoneal lead course and device infection
by: Michael R. Kaufmann, MD, et al.
Published: (2016-05-01)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
by: Naga VA Kommuri, et al.
Published: (2010-01-01)

Lead Macrodislodgement of a Subcutaneous Implantable Cardioverter-Defibrillator Results in a Reel Problem
by: Rayan S. El-Zein, DO, et al.
Published: (2021-03-01)

Usefulness of lead repositioning from left to right sternal border for a patient with subcutaneous implantable cardioverter defibrillator showing high defibrillation threshold
by: Yasushi Wakabayashi, et al.
Published: (2019-02-01)

Incidence of ineffective safety margin testing (<10 J) and efficacy of routine subcutaneous array insertion during implantable cardioverter defibrillator implantation
by: Marc-Alexander Ohlow, et al.
Published: (2016-03-01)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
by: Sing-Chien Yap, MD, PhD, et al.
Published: (2015-05-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

Magnets and implantable cardioverter defibrillators: What′s the problem?
by: Yiliam F Rodriguez-Blanco, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_0mlks65iq96blgrm4buvm382a6